Levi Garraway, Roche's chief medical officer and head of global product development. Roche has built the evidence for its oral BTK inhibitor fenebrutinib in multiple sclerosis (MS) with two phase 3 ...
Odejinmi, M. , Thompson, S. and Wastesicoot, D. (2025) Community-Led Transformation of the Housing and Education Systems by York Factory First Nation, Manitoba, Canada. Open Journal of Social Sciences ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback